Child with Asthma Exacerbation and Silent Chest
A 9-year-old boy with a history of asthma is brought to the ED with worsening shortness of breath and wheezing for 2 days. He has been using his albuterol inhaler every 2 hours with minimal relief. On arrival, he is sitting upright, speaking in short phrases, and appears anxious. His respiratory rate is 40, heart rate 140, oxygen saturation 89% on room air, and peak expiratory flow (PEF) is 40% of predicted. On auscultation, he has diffuse wheezing, but the wheezing is becoming quieter. He has subcostal retractions and nasal flaring. The ED has a protocol for asthma: administer oxygen, nebulized albuterol, and ipratropium, and consider systemic corticosteroids. The physician must decide on the next step, including the use of magnesium sulfate and the need for intubation. The child weighs 30 kg. The ED has a non-rebreather mask, a nebulizer, and IV access. The physician notes that the wheezing is diminishing and the chest is becoming silent.
1. What is the significance of the decreasing wheezing and silent chest in this child? What is the most appropriate immediate management?
Read the worked answer
A silent chest in a child with asthma is a sign of severe, life-threatening asthma. Decreasing wheezing indicates poor air movement due to severe bronchospasm and mucus plugging, not improvement. The child is showing signs of impending respiratory failure: altered mental status (anxiety), use of accessory muscles, tachypnea, hypoxemia, and a silent chest. Immediate management: provide high-flow oxygen to maintain SpO2 ≥94%, start continuous nebulized albuterol (e.g., 0.5 mL of 0.5% solution in 3 mL NS) with ipratropium (0.5 mg) and administer systemic corticosteroids (e.g., methylprednisolone 1-2 mg/kg IV or prednisone 1-2 mg/kg PO). Consider IV magnesium sulfate 50 mg/kg (max 2 g) over 20 minutes. If the child is not improving, prepare for intubation with a non-rebreather bag-valve-mask and consider ketamine for sedation (1-2 mg/kg IV) due to its bronchodilator properties. Avoid positive pressure ventilation if possible, but if needed, use low tidal volumes and high respiratory rates. Also, consider heliox (70:30 helium:oxygen) if available. The key is to recognize the silent chest as a medical emergency and escalate therapy rapidly.
2. If the child requires intubation, what special considerations apply to ventilation in a child with severe asthma? Discuss the risks and strategies to minimize them.
Read the worked answer
Intubation in severe asthma is high-risk due to dynamic hyperinflation, air trapping, and barotrauma. Special considerations: preoxygenate with 100% oxygen, use a ketamine-based induction (bronchodilator) and avoid histamine-releasing drugs. Use a large-bore endotracheal tube to facilitate suctioning and bronchoscopy if needed. After intubation, use controlled hypoventilation with a low respiratory rate (e.g., 8-12 breaths/min) and low tidal volumes (6-8 mL/kg) to allow adequate exhalation and avoid air trapping. Maintain a long expiratory time (I:E ratio of 1:4 or more). Permissive hypercapnia is acceptable (target PaCO2 50-80 mmHg) as long as pH >7.20. Monitor for auto-PEEP by observing the flow-time curve; if present, disconnect the patient from the ventilator briefly to allow exhalation. Use minimal PEEP (0-5 cm H2O) to avoid worsening air trapping. Sedate and paralyze the patient to reduce work of breathing and prevent dyssynchrony. Consider inhaled anesthetics (e.g., sevoflurane) if available. Monitor for complications: pneumothorax, hypotension, and cardiac arrest. Have a low threshold for needle decompression if pneumothorax suspected. After stabilization, continue bronchodilators via the ventilator circuit and corticosteroids. Consult pediatric critical care and consider ECMO if refractory.